Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2026-03-26 00:00:00 ET · period of report 2026-03-24 · accession 0001816160-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-26 | 2026-03-25+ | ACAD | Kihara James | PRINCIPAL ACCOUNTING Off | S - Sale+OE | $21.57 | -1,942 | 26.9K | -7% | -$41.9K |
| DM | 2026-03-26 | 2026-03-24+ | ACAD | Kihara James | PRINCIPAL ACCOUNTING Off | M - OptEx | — | +3,769 | 26.7K | +16% | — |
| DM | 2026-03-26 | 2026-03-24+ | ACAD | Kihara James | PRINCIPAL ACCOUNTING Off | M - OptEx | $0.00 | -3,769 | 4,284 | -47% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-25 | S | D | 833 | $21.47 | 25,852 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-25 | M | A | 2,142 | — | 27,994 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 3 | Common | Common Stock | 2026-03-26 | S | D | 1,097 | $21.65 | 26,897 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-26 | S | D | 12 | $21.73 | 26,885 | D | — | — | |
| 5 | Common | Common Stock | 2026-03-24 | M | A | 1,627 | — | 26,685 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 6 | Derivative | Restricted Stock Units | 2026-03-24 | M | D | 1,627 | $0.00 | 4,883 | D | — · — to — | 1,627 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F3) The restricted stock units vest in four equal annual installments beginning March 24, 2026. |
| 7 | Derivative | Restricted Stock Units | 2026-03-25 | M | D | 2,142 | $0.00 | 4,284 | D | — · — to — | 2,142 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F4) The restricted stock units vest in four equal annual installments beginning March 25, 2025. |